InsidersTradesSigma
Follow the 뉴로핏 share price and the full management transaction log of the company, a listed issuer based in South Korea. Shares are listed on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 뉴로핏 has published 9 insider filings. Market capitalisation: €89bn. The latest transaction was filed on 1 June 2026 (Purchase). Among the most active insiders: 김동현. All data is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
9 of 9 declarations
Neurofit is a company operating in the health and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative solutions for patient well-being and health.